Topic: drug delivery
-
Aerska's $39M Boost Targets Brain-Delivery for RNA Medicines
Aerska, a Dublin biotech firm, has secured $39 million to develop a delivery system that can transport advanced genetic medicines across the protective blood-brain barrier to treat neurodegenerative diseases. The company's technology aims to use RNA interference to target and reduce the productio...
Read More » -
Nephrogen's AI Gene Therapy Aims to Reverse Kidney Disease
Demetri Maxim was inspired by his family's experience with Polycystic Kidney Disease (PKD), which he also inherited, leading him to pursue a cure for genetic kidney disorders. In 2022, he founded Nephrogen, a biotech startup that uses AI and advanced screening to develop an efficient delivery sys...
Read More »